Report Library
View More
Gene, Cell, & RNA Therapy Landscape...
October 28, 2024
Datamonitor Healthcare Infectious D...
October 25, 2024
Datamonitor Healthcare CNS: Fragile...
October 25, 2024
Datamonitor Healthcare CV&Met: Sick...
October 25, 2024
Datamonitor Healthcare CV&Met Disea...
October 22, 2024
Datamonitor Healthcare CV&Met Disea...
October 22, 2024
Podcast: Insights from ESMO
October 21, 2024
Datamonitor Healthcare Oncology Dis...
October 21, 2024
Datamonitor Healthcare I&I Disease ...
October 21, 2024
Datamonitor Healthcare I&I: Dry Eye...
October 17, 2024
Datamonitor Healthcare I&I: Heredit...
October 17, 2024
Chronic Myeloid Leukemia (CML) KOL ...
October 14, 2024
Chronic Myeloid Leukemia (CML) KOL ...
October 14, 2024
Datamonitor Healthcare Oncology Dis...
October 14, 2024
Datamonitor Healthcare CV&Met Disea...
October 11, 2024
Exploring the Asia-Pacific Clinical...
October 10, 2024
2024 Clinical Trials Roundup
October 10, 2024
Datamonitor Healthcare Infectious D...
October 10, 2024
HIV Treatment KOL Interview – Germa...
October 9, 2024
HIV Treatment KOL Interview – Ital...
October 9, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 10/21/24 | Novo Nordisk (NVO) | Rybelsus for Diabetes Mellitus, Type II | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/21/24 | Novo Nordisk (NVO) | Rybelsus for Cardiovascular Disease | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/17/24 | Merck (MRK) | Clesrovimab for Respiratory Syncytial Virus (RSV) Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/17/24 | Supernus Pharmaceuticals (SUPN) | SPN-820 for Major Depressive Disorder (MDD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/16/24 | Merck (MRK) | Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 09/12/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/30/2024 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 10/16/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/25/2024 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 10/25/2024 | Subscribers Only | Subscribers Only | Trial Data - Other |